IP Library › Assignment 023027/0804
Patent Assignment
Reel/Frame 023027/0804

Assignment of Assignor's Interest

Recorded: 2009-07-27 Received: 2009-07-30 Pages: 30
Assignor
BAYER PHARMACEUTICALS CORPORATION
Executed: 2007-12-19
Assignee
BAYER HEALTHCARE LLC
555 WHITE PLAINS ROAD, TARRYTOWN, NY, 10591, UNITED STATES
Covered Properties (100)
Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders
Application: 11/886,132 →
Pyrimidine Derivatives
Application: 11/918,016 →
Pyrimidine Derivatives
Application: 11/887,976 →
Selective neuropeptide y2 receptor agonists
Application: 10/576,674 →
Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity
Application: 11/918,836 →
Pituitary Adenylate Cyclase Activating Peptide (PACAP) Receptor (VPAC2) Agonists and Their Pharmacological Methods of Use
Application: 10/586,124 →
Substituted Pyrazolyl Urea Derivatives Useful in the Treatment of Cancer
Application: 11/579,093 →
Hydroxy Methyl Phenyl Pyrazolyl Urea Compound Useful in the Treatment of Cancer
Hydroxy Methyl Phenyl Pyrazolyl Urea Compound Useful in the Treatment of Cancer
Regulation of Human Transmembrane Serine Protease
Application: 11/936,155 →
Pituitary adenylate cyclase acivating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
Application: 11/919,819 →
Inhibition of Raf Kinase Using Quinolyl, Isoquinolyl or Pyridyl Ureas
Application: 11/932,269 →
Mn/Ca Ix and Egfr Pathway Inhibition
Application: 11/927,150 →
Ca Ix-Specific Inhibitors
Application: 11/924,587 →
Mn/CA9 Splice Variants
Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
Application: 60/995,147 →
Anilinopyrazole Derivatives Useful for the Treatment of Diabetes
Application: 11/897,620 →
Preparation and Use of Biphenyl-4-Yl-Carbonylamino Acid Derivatives for the Treatment of Obesity
Application: 11/665,317 →
Substituted Thieno[3,2-D]Pyrimidines as Rho Kinase Inhibitors
Application: 11/733,045 →
MN/CA IX and MAPK inhibition
Application: 11/726,065 →
Peptides and Peptidomimetics with Structural Similarity to Human P53 That Activate P53 Function
Application: 11/684,285 →
Mn/Ca Ix/CA9 and Renal Cancer Prognosis
Application: 11/578,744 →
Soluble MN/CA IX and Transitional Cell Carcinoma
Application: 60/890,735 →
Mn Gene and Protein
Application: 11/706,101 →
Hydroxy methyl phenyl pyrazolyl urea compound useful in the treatment of cancer
Application: 60/875,830 →
Hydroxy methyl phenyl pyrazolyl urea compound useful in the treatment of cancer
Application: 60/875,831 →
Anti-Mn Antibodies and Methods of Using Same
Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
Urea Compounds Useful in the Treatment of Cancer
Pyrrolotriazine Derivatives Useful for Treating Cancer Through Inhibition of Aurora Kinase
Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes
Application: 11/596,959 →
Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
Application: 11/596,913 →
MN/CA IX and kidney cancer
Application: 60/855,507 →
MN/CA IX splice variants
Application: 60/851,398 →
Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative Conditions
Application: 10/594,978 →
Mn/Ca Ix and Cancer Prognosis
Application: 10/575,300 →
Anilinopyrazole Derivatives Useful for the Treatment of Diabetes
Fused Tricyclic Heterocycles Useful for Treating Hyper-Proliferative Disorders
Application: 11/512,032 →
Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity
Hydroxy-Tetrahydro-Naphthalenylurea Derivatives
Application: 10/545,556 →
Anti-Anti-Idiotype Antibodies to Mn Proteins and Mn Polypeptides
Application: 11/448,576 →
Glucagon-Like Peptide 1 (Glp-1) Receptor Agonists and Their Pharmacological Methods of Use
Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation
Application: 11/429,136 →
Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor (VPAC2) Agonists and Their Pharmacological Methods of Use
Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity
Pyrimidine Derivatives
Pyrimidine Derivatives
Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders
Application: 10/573,227 →
Mn Gene and Protein
Application: 11/356,568 →
Rho-kinase inhibitors
Application: 11/354,977 →
Rho-kinase inhibitors
Application: 11/354,978 →
Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity
Application: 11/341,197 →
Benzofuran Derivatives Useful for Treating Hyper-Proliferative Disorders
Application: 10/566,343 →
Methods for screening and identifying compounds
Application: 11/266,030 →
Indole Acetic Acid Derivatives and Their Use as Pharmaceutical Agents
Application: 10/555,024 →
Hydroxamic acids useful in the treatment of hyper-proliferative disorders
Application: 10/554,390 →
Pyridine Derivatives
Application: 11/240,728 →
Pyridine Derivatives
Application: 11/240,867 →
Ca Ix-Specific Inhibitors
Application: 11/222,986 →
Peptides Acting as Both Glp-1 Receptor Agonists and Glucagon Receptor Antagonists and Their Pharmacological Methods of Use
Application: 11/213,023 →
Peptides Acting as Both Glp-1 Receptor Agonists and Glucagon Receptor Antagonists and Their Pharmacological Methods of Use
Application: 11/213,026 →
Peptides Acting as Both Glp-1 Receptor Agonists and Glucagon Receptor Antagonists and Their Pharmacological Methods of Use
Application: 11/213,083 →
Methods using peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists for the treatment of disease
Application: 11/213,024 →
Peptides Acting as Both Glp-1 Receptor Agonists and Glucagon Receptor Antagonists and Their Pharmacological Methods of Use
Application: 11/212,439 →
Peptides Acting as Both Glp-1 Receptor Agonists and Glucagon Receptor Antagonists and Their Pharmacological Methods of Use
Application: 11/213,087 →
MN and hypoxia
Application: 11/166,997 →
Pegylation of Vasoactive Intestinal Peptide (Vip)/Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (VPAC2) Agonists and Methods of Use
Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation
Application: 10/537,630 →
5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes
Optically Active Pyridine Derivative and a Medicament Containing the Same
Application: 10/508,107 →
Rho-kinase inhibitors
Application: 11/111,704 →
Rho-kinase inhibitors
Application: 11/107,793 →
Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders
Application: 11/078,681 →
Method and Apparatus for Determining the Context of a Device
Neuropeptide Y4 receptor agonists
Application: 60/655,727 →
Furo[2.3-B]Pyridine Derivatives for the Treatment of Hyper-Proliferative Disorders
Application: 10/515,605 →
Arylsulfonamide Derivatives for Use as CCR3 Antagonists in the Treatment of Inflammatory and Immunological Disorders
Application: 10/489,029 →
Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation
Application: 10/949,119 →
Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents
Application: 10/506,270 →
Soluble Form of Carbonic Anhydrase Ix (S-Ca Ix), Assays to Detect S-Ca Ix, Ca Ix's Coexpression with Her-2/Neu/C-Erbb-2, and Ca Ix-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
Application: 10/921,590 →
Method for Assaying Enzyme Activity
Application: 10/911,242 →
Benzofuran and Benzothiophene Derivatives Useful in the Treatmint of Hyper-Proliferative Disorders
Application: 10/501,689 →
Fused Tricyclic Heterocycles Useful for Treating Hyper-Proliferative Disoroders
Application: 10/501,690 →
Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 3 (R3) Agonists and Their Pharmacological Methods of Use
Application: 10/892,981 →
Mn Gene and Protein
Application: 10/888,694 →
stabilized peptide formulations
Application: 10/500,680 →
Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives
Application: 10/498,935 →
Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
Application: 60/572,906 →
Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity
Application: 10/839,833 →
Regulation of Human Transmembrane Serine Protease
Application: 10/806,370 →
MN gene and protein
Application: 10/795,933 →
Ca Ix-Specific Inhibitors
Application: 10/723,795 →
Substituted Pyridines and Pyridazines with Angiogenesis Inhibiting Activity
Application: 10/720,702 →
Anilinopyrazole Derivatives Useful for the Treatment of Diabetes
Application: 10/719,485 →
Modified Glp-1 Receptor Agonists and Their Pharmacological Methods of Use
PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (PACAP) RECEPTOR (VPAC2) agonist peptide
Application: 10/618,126 →
Pyridine Derivatives
Application: 10/402,500 →
Formulation Strategies in Stabilizing Peptides in Organic Solvents and in Dried States
Rho-Kinase Inhibitors
Application: 10/349,177 →